Pure Biologics SA (PQB) Financial Statements
Pure Biologics SA Financial Overview
Pure Biologics SA's market cap is currently $75.58M. The company's EPS TTM is $-1.45; its P/E ratio is -2.02; Pure Biologics SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 95.00K | $ 662.00K | $ 254.00K |
| Gross Profit | $ -159.00K | $ -46.00K | $ -2.57M | $ -5.41M | $ -4.03M |
| Operating Income | $ -6.33M | $ -12.38M | $ -31.72M | $ -24.63M | $ -10.48M |
| EBITDA | $ -6.17M | $ -12.24M | $ -26.08M | $ -22.78M | $ -8.62M |
| Net Income | $ -9.82M | $ -19.43M | $ -35.69M | $ -26.37M | $ -13.07M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.00K | $ 313.00K | $ 3.61M | $ 7.18M | $ 32.93M |
| Total Assets | $ 4.94M | $ 2.34M | $ 22.74M | $ 33.01M | $ 47.19M |
| Total Debt | $ 16.01M | $ 14.06M | $ 12.94M | $ 2.86M | $ 3.11M |
| Net Debt | $ 16.00M | $ 13.75M | $ 9.33M | $ 602.00K | $ -3.06M |
| Total Liabilities | $ 19.09M | $ 15.46M | $ 20.84M | $ 14.71M | $ 7.70M |
| Stockholders' Equity | $ -14.15M | $ -13.12M | $ 1.89M | $ 18.30M | $ 39.49M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.28M | $ -10.83M | $ -23.44M | $ -23.14M | $ -24.71M |
| Operating Cash Flow | $ -6.28M | $ -10.83M | $ -23.26M | $ -17.39M | $ -24.04M |
| Investing Cash Flow | $ 939.00K | $ 3.56M | $ 391.00K | $ 15.35M | $ -28.48M |
| Financing Cash Flow | $ 5.04M | $ 3.98M | $ 24.22M | $ -1.88M | $ 49.73M |
Currency in PLN
